Seminars & Events

Friday, October 4, 2013: Dr. Laurie Ryan, SMCM '86 (National Institute on Aging) will speak on "Alzheimer's Disease: Targets and Treatments" at 3:00 pm in Goodpaster Hall 195.

Monday, October 21, 2013: Dr. Greg Elmer (University of Maryland Baltimore) will speak on "Domains and Constructs in Motivation: Where Does the Habenula Fit In?" at 4:45 pm in Goodpaster Hall 195

Friday, October 25, 2013:  Dr. Terry Davidson (American University) will speak on "Why We Overeat and Become Obese?  It Could be What We Think!" at 3:00 pm in Goodpaster Hall 195.

+ VIEW CALENDAR

Alumni Highlight

Dr. Gwen Calhoon '06 recently received her Ph.D. in Neuroscience from the University of Maryland Baltimore, and was inducted into Nu Rho Psi.

+ MORE

 

   

 

 

 

SMP Spotlight

Katie Gluskin and Jeff Haus present their SMP
Katie Gluskin and Jeff Haus, "Entorhinal Cortex Lesions, Habituation, and Latent Inhibition," 2013. Gluskin and Haus, the 2013 co-winners of the Neuroscience Award, infused a neurotoxin into the entorhinal cortex of rats to induce a lesion, and measured the resulting habituation and latent inhibition behavior within a fear conditioning paradigm.

+ MORE

Burke, Jesse (2012).  Effects of adolescent exposure to olanzapine on adulthood rodents. (Mentor: A. Bailey)

Abstract 

With greater understanding of certain mental illnesses, there comes the ability to identify and start treatment at an earlier age. Starting medication is one line of defense when a mental illness is identified, and when that illness is identified in adolescence this process is no different. The complication arises when introduction of these drugs occurs during adolescence, a period when the nervous system is rapidly changing. Studying the long-term effects of starting medications at an early age is critical for understanding if the treatment of symptoms outweighs the potential behavioral/neurobiological consequences in adulthood. In the current study, we administered olanzapine (OLA), a common atypical antipsychotic that is prescribed for schizophrenia, bipolar disorder, and autism to adolescent rats to see how this affected conditioned reinforcement through a Pavlovian reinforcer devaluation task in adulthood. We also wanted to see if adolescent OLA treatment affected fear and appetitive extinction tasks in adulthood. We did not find any significant impairment between vehicle and OLA treated rodents in conditioned reinforcement or appetitive extinction, although some interesting behavioral trends were noted.